会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 91. 发明申请
    • BLOOD ACCESS ASSEMBLY FOR ARTIFICIAL LUNG AND RIGHT VENTRICULAR ASSIST DEVICE
    • 用于人造肺和右心室辅助装置的血液通入装置
    • US20110040241A1
    • 2011-02-17
    • US12539110
    • 2009-08-11
    • Dongfang WangJoseph B. Zwischenberger
    • Dongfang WangJoseph B. Zwischenberger
    • A61M5/00A61M1/00
    • A61M1/3653A61M1/3655A61M1/3656A61M1/3659
    • A system for providing access to at least one heart chamber for delivering and/or removing a fluid includes a selectively occludable conduit defining a lumen for providing access to an interior of at least one heart chamber from an exterior of a chest wall of the patient, and a dual lumen cannula adapted for passing through an interior lumen of the conduit. The selectively occludable conduit includes at least one balloon closure for substantially sealing an end of the conduit in fluid communication with the chamber of the heart. The dual lumen cannula includes a first, drainage lumen having at least one aperture for removing a fluid from the interior of the heart chamber, and a second, delivery lumen for delivering a fluid into the interior of the heart chamber. The delivery lumen may include an extendable infusion sleeve for delivering a fluid into an interior of the heart.
    • 用于提供进入至少一个心室的输送和/或去除流体的系统包括限定内腔的选择性可闭塞导管,用于从患者胸壁的外部提供进入至少一个心室的内部, 以及适于穿过导管的内腔的双腔插管。 选择性可闭塞管道包括至少一个气囊盖,用于基本上密封导管的与心脏腔室流体连通的端部。 双腔套管包括具有至少一个用于从心脏腔室内部移除流体的孔的第一排液腔和用于将流体输送到心室的内部的第二输送腔。 输送腔可以包括用于将流体输送到心脏内部的可伸展输液套筒。
    • 95. 发明申请
    • SELF ADJUSTING VENOUS EQUALIZING GRAFT
    • 自调整均衡平衡
    • US20100234789A1
    • 2010-09-16
    • US12723032
    • 2010-03-12
    • Stanley BatisteSteven Achstein
    • Stanley BatisteSteven Achstein
    • A61M1/00
    • A61M1/3653A61M1/3655A61M1/3659A61M1/3661
    • A self adjusting venous equalizing graft (SAVE graft) which provides a self regulating stenosis is provided herein. The SAVE graft responds to increases or decreases in blood pressure which allows a higher pressure at the graft's arterial end and a lower pressure at the graft's venous end. This is ideal in that it mimics the natural pressure of a patient's circulatory system. A dialysis machine may draw blood at the arterial end, dialyze the blood, and return the blood to the patient at the graft's venous end. The lower pressure at the venous end prevents damage to the patient's vein. The SAVE graft may comprise a deformable stenosis control diaphragm or a venous controlled pressure nozzle which may expand or contract in response to blood pressure to self regulate the stenosis provided by the SAVE graft.
    • 本文提供了一种提供自我调节狭窄的自调节静脉平衡移植物(SAVE移植物)。 SAVE移植物对血压的升高或降低作出反应,这允许移植物动脉末端的压力更高,移植物静脉末端的压力较低。 这是理想的,因为它模仿了患者循环系统的自然压力。 透析机可以在动脉端吸血,透血,并在移植静脉端将血液返回给患者。 静脉端的较低压力可防止患者静脉损伤。 SAVE移植物可以包括可变形狭窄控制隔膜或静脉控制压力喷嘴,其可以响应于血压而膨胀或收缩以自我调节由SAVE移植物提供的狭窄。
    • 96. 再颁专利
    • Squitieri hemodialysis and vascular access systems
    • Squitieri血液透析和血管通路系统
    • USRE41448E1
    • 2010-07-20
    • US10219998
    • 2002-08-15
    • Rafael P. Squitieri
    • Rafael P. Squitieri
    • A61M37/00
    • A61M1/3653A61M1/3655A61M39/0208A61M2005/1581A61M2039/0211A61M2039/0258
    • A hemodialysis and vascular access system comprises a subcutaneous composite PTFE silastic arteriovenous fistula having an indwelling silastic venous end which is inserted percutaneously into a vein and a PTFE arterial end which is anastomosed to an artery. Access to a blood stream within the system is gained by direct puncture of needle(s) into a needle receiving site having a tubular passage within a metal or plastic frame and a silicone upper surface through which needle(s) are inserted. In an alternate embodiment of the invention, percutaneous access to a blood stream may be gained by placing needles directly into the system (i.e. into the PTFE arterial end). The invention also proposes an additional embodiment having an arterialized indwelling venous catheter where blood flows from an artery through a tube and a port into an arterial reservoir and is returned to a vein via a port and a venous outlet tube distinct and distant from the area where the blood from the artery enters the arterial reservoir. The site where blood is returned to the vein is not directly fixed to the venous wall but is free floating within the vein. This system provides a hemodialysis and venous access graft which has superior longevity and performance, is easier to implant and is much more user friendly.
    • 血液透析和血管通路系统包括皮下复合PTFE硅橡胶动静脉瘘,其具有经皮插入静脉的留置硅橡胶静脉端和与动脉吻合的PTFE动脉末端。 通过将针直接穿刺到金属或塑料框架内具有管状通道的针接收位置和插入针的硅树脂上表面来获得系统内的血流。 在本发明的替代实施例中,可以通过将针直接放入系统(即进入PTFE动脉端)来获得对血流的经皮进入。 本发明还提出了一种另外的实施例,其具有动脉留置静脉导管,其中血液从动脉通过管和端口流入动脉储存器,并经由口和静脉出口管返回到静脉,所述口和静脉出口管不同于 动脉血液进入动脉血管。 血液返回静脉的部位不直接固定在静脉壁上,而是静脉内自由浮动。 该系统提供血液透析和静脉进入移植物,其具有优越的寿命和性能,更容易植入并且更加用户友好。
    • 97. 发明申请
    • METHOD OF MONITORING HYPERTENSIVE HAEMODIALYSIS PATIENTS
    • 监测高血压病人的方法
    • US20100105990A1
    • 2010-04-29
    • US12523460
    • 2008-01-16
    • Bernard Bene
    • Bernard Bene
    • A61B5/00
    • A61M1/3656A61M1/3653A61M1/3655A61M1/3658G06F19/00G06F19/3481G16H50/30
    • The invention relates to a calculation and control system for determining whether a patient intended to follow several sessions of hemodialysis treatment falls or not within one group among several groups of hypertension-affected patients, the system comprising: a) means for determining the value of at least one parameter representing the mass interdialytic evolution of the patient, for at least two sessions, b) means for determining the value of at least one parameter representing the plasmatic conductivity of the patient for at least two sessions, c) means for determining the value of a parameter representing the ionic mass transfer of the treatment for at least two sessions, d) programmed means for determining whether the patient falls or not within a group of hypertension-affected patients as a function of the interdialytic mass evolution of the patient, and/or of the plasmatic conductivity and/or of the ionic mass transfer.
    • 本发明涉及一种计算和控制系统,用于确定是否要在几组血液透析治疗之间进行多次血液透析治疗的患者在几组受高血压影响的患者中落在一组内,该系统包括:a)用于确定在 用于至少两个会话的至少一个参数,表示患者的质量间盘间变化; b)用于确定表示至少两个会话的患者的血浆电导率的至少一个参数的值的装置,c)用于确定所述值的装置 表示治疗至少两次的离子质量转移的参数,d)用于确定患者是否在一组受高血压影响的患者内下降的程序化手段,作为患者的透析间质量演变的函数,以及 /或血浆导电性和/或离子质量转移。
    • 98. 发明申请
    • TUBULAR VASCULAR TRANSPLANT
    • 管状血管移植
    • US20090326431A1
    • 2009-12-31
    • US12309798
    • 2007-07-20
    • Michael HeiseChristoph Heidenahain
    • Michael HeiseChristoph Heidenahain
    • A61M1/00
    • A61F2/06A61F2/064A61F2002/068A61M1/3655
    • A tubular vascular transplant (1, 1′, 1″, 1′″) serves for connecting vessels in the human body. The transplant, in particular made of expanded polytetrafluoroethylene (ePTFE), can preferably be used for an arteriovenous shunt for carrying out a dialysis. The transplant is connected by its first, proximal end to a vessel, for example an artery (2), and by its distal end to another location of the same vessel or to a different vessel, for example a vein (3). The lumen of the transplant (1, 1′, 1″, and 1′″) widens in a steadily conical manner in the region of its distal end and forms a diffuser (8) there. The cone angle (a) of the wall of the diffuser (8) with respect to the central flow direction of the blood in the transplant (1′, 1″, 1′″) is preferably 6° to 7°. In the region of the diffuser (8), preferably at least one, preferably planar, dividing wall (11, 11′, 11a, and 11b) is provided, running in the central flow direction of the blood. This makes it possible to prevent the formation of an intimal hyperplasia and a pseudointima.
    • 管状血管移植物(1,1',1“,1”)用于连接人体内的血管。 特别是由膨胀聚四氟乙烯(ePTFE)制成的移植物可优选用于进行透析的动静脉分流。 移植物通过其第一近端连接到血管,例如动脉(2),并且通过其远端连接到同一血管的另一位置,或连接到不同的血管,例如静脉(3)。 移植物的管腔(1,1',1“和1”“)在其远端的区域中以稳定的锥形方式变宽,并在其上形成扩散器(8)。 扩散器(8)的壁相对于移植体(1',1“,1”“)中的血液的中心流动方向的锥角(a)优选为6°至7°。 在扩散器(8)的区域中,优选地设置有沿着血液的中心流动方向延伸的至少一个优选的平面的分隔壁(11,11',11a和11b)。 这使得可以防止内膜增生和假节点的形成。